π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The primary objective is to evaluate the efficacy of monthly 225 mg sc frem...
Status
Completed
Location
Teva Investigational Site 14330
Start Date
2019-09-13
Trial ID
NCT04041284
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-08
Trial ID
NCT01165723
Treatments Being Tested
Prior to administering PF-04427429 to patients we wish to increase the unde...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-08
Trial ID
NCT01147432
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, pharmac...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-10
Trial ID
NCT01511497
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-12
Trial ID
NCT01011296
Treatments Being Tested
The purpose is to study the safety, tolerability, pharmacokinetics and phar...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-05
Trial ID
NCT01117233
Treatments Being Tested